Skip to main content

Merck Completes €3.40 Billion Senior Notes Offering

Press releases | May 30, 2024

Fried Frank acted as counsel to MSD Netherlands Capital B.V., a private company with limited liability incorporated and existing under the laws of the Netherlands and a wholly-owned finance subsidiary of Merck & Co., Inc., and Merck & Co., Inc., as parent guarantor, in its €3.40 billion, four-tranche registered public offering of Euro-denominated senior notes, which are listed on the New York Stock Exchange. Merck & Co., Inc. is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. 

The Fried Frank team was led by corporate partners Daniel J. Bursky and Andrew B. Barkan and included corporate partner John Lawrence, tax partner Joseph E. Fox, corporate associates Daniel Neuman and Charles Stern, and corporate law clerk Camilla Oliva.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.